Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Thrombosis and Haemostasis|June 4, 2008
Fluid loss does not explain coagulation activation during air travelAnja J M Schreijer, Suzanne C Cannegieter, Marianna Caramella, et al.
British Journal of Haematology|September 6, 2003
Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disordersGiuliana Muti, Catherine Klersy, Fausto Baldanti, et al.
Blood|January 12, 2008
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosisFrancesco Passamonti, Elisa Rumi, Marianna Caramella, et al.
Blood|December 17, 2009
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)Francesco Passamonti, Francisco Cervantes, Alessandro Maria Vannucchi, et al.
Haematologica|November 17, 2018
EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysisAlessandro M Vannucchi, Peter A W Te Boekhorst, Claire N Harrison, et al.
European Journal of Haematology|June 17, 2021
Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 studyEster Pungolino, Mariella D'adda, Gabriella De Canal, et al.
Blood Advances|February 7, 2022
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosisMargherita Maffioli, Barbara Mora, Somedeb Ball, et al.
Cancer Medicine|June 8, 2019
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patientsBarbara Mora, Elisa Rumi, Paola Guglielmelli, et al.
Ejhaem|August 21, 2023
Incidence of blast phase in myelofibrosis according to anemia severityBarbara Mora, Margherita Maffioli, Elisa Rumi, et al.
British Journal of Haematology|February 9, 2022
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL studyElena Maria Elli, Ambra Di Veroli, Daniela Bartoletti, et al.
Pageof 2